Rating History for Pear Therapeutics (PEAR) by Chardan

More Stocks Rated by Chardan | Latest Ratings for PEAR
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/20/2023 Keay Nakae Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.39
(0.03)		 -92.31% Details